A reasonable chance it could cause serious harm or death.
Presence of Particulate Matter
| Brand name | IBUPROFEN LYSINE |
| Generic name | IBUPROFEN LYSINE |
| Active ingredient(s) | IBUPROFEN LYSINE |
| Distributed by / for | X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; |
| NDC | 39822-1030-1 |
| Full product label | Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Single-Dose Vials per carton (NDC 39822-1030-2); Rx only, Distributed by: X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. |
| Recalling firm | X-Gen Pharmaceuticals Inc. |
| Distribution | Nationwide in the USA. |
| Quantity | 2593 cartons |
| Recall initiated | 2017-02-08 |
| Report date | 2017-04-12 |
| Recall completed | 2020-06-10 |
| Recall number | D-0637-2017 |
| Classification | Class I |
| FDA status | Terminated |
| Origin on file | Horseheads NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗